Disruption of the MDM2-p53 interaction synergizes with MEK inhibition to induce cell death and promote tumor regression in p53 wild-type, Ras or Raf-mutant tumor models

被引：0
|
作者：
Meaux, Isabelle [1 ]
Nicolas, Jean-Paul [1 ]
Rowley, Steve [2 ]
Sidhu, Sukhvinder [1 ]
Herve, Francoise [1 ]
Dassencourt, Laurent [1 ]
Windenberger, Fanny [1 ]
Gorge-Bernat, Dimitri [1 ]
Pannier, Pascal [1 ]
Bergstrom, Donald [2 ]
Debussche, Laurent [1 ]
Watters, James [2 ]
机构：
[1] Sanofi Oncol, Vitry Sur Seine, France
[2] Sanofi Oncol, Cambridge, MA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-805
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
805
引用
收藏
页数：2
相关论文
共 50 条
  • [1] TUMOR SUPPRESSOR P53 - ANALYSIS OF WILD-TYPE AND MUTANT P53 COMPLEXES
    MILNER, J
    MEDCALF, EA
    COOK, AC
    MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (01) : 12 - 19
  • [2] Chaperoning of Mutant p53 Protein by Wild-type p53 Protein Causes Hypoxic Tumor Regression
    Gogna, Rajan
    Madan, Esha
    Kuppusamy, Periannan
    Pati, Uttam
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (04) : 2907 - 2914
  • [3] Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas
    Wu, Jianyuan
    Li, Qingdi Quentin
    Zhou, Huiping
    Lu, Yinying
    Li, Jueli M.
    Ma, Yao
    Wang, Li
    Fu, Tingting
    Gong, Xingjiang
    Weintraub, Michael
    Wu, Shuangchan
    Ding, Hong
    MEDICAL ONCOLOGY, 2014, 31 (07)
  • [4] Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas
    Jianyuan Wu
    Qingdi Quentin Li
    Huiping Zhou
    Yinying Lu
    Jueli M. Li
    Yao Ma
    Li Wang
    Tingting Fu
    Xingjiang Gong
    Michael Weintraub
    Shuangchan Wu
    Hong Ding
    Medical Oncology, 2014, 31
  • [5] An Inhibitor for the MDM2-p53 Interaction Produces Synergistic Cytotoxicity with Oncolytic Adenoviruses on Mesothelioma with Wild-Type p53 Genotype
    Tagawa, Masatoshi
    Nguyen, Thao T. T.
    Morinaga, Takao
    Zhong, Boya
    Hanazono, Michiko
    Kubo, Shuji
    Shingyoji, Masato
    Tada, Yuji
    Tatsumi, Koichiro
    Shimada, Hideaki
    Hiroshima, Kenzo
    MOLECULAR THERAPY, 2017, 25 (05) : 280 - 280
  • [6] ADP-ribosylation of p53 tumor suppressor protein: Mutant but not wild-type p53 is modified
    WesierskaGadek, J
    BugajskaSchretter, A
    Cerni, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1996, 62 (01) : 90 - 101
  • [7] The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth
    Cadwell, C
    Zambetti, GP
    GENE, 2001, 277 (1-2) : 15 - 30
  • [8] FUNCTIONAL INTERACTION OF WILD-TYPE AND MUTANT P53 TRANSFECTED INTO HUMAN TUMOR-CELL LINES CARRYING ACTIVATED RAS GENES
    SCHAFER, R
    SCHWARTEWALDHOFF, I
    OBERHUBER, H
    SHARMA, S
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 229 - 229
  • [9] Mutant and Wild-Type Tumor Suppressor p53 Induces p300 Autoacetylation
    Kaypee, Stephanie
    Sahadevan, Smitha Asoka
    Patil, Shilpa
    Ghosh, Piya
    Roy, Neeladri Sekhar
    Roy, Siddhartha
    Kundu, Tapas K.
    ISCIENCE, 2018, 4 : 260 - +
  • [10] Comparable radiation sensitivity in p53 wild-type and p53 deficient tumor cells associated with different cell death modalities
    Ping Li
    Xiongxiong Liu
    Ting Zhao
    Feifei Li
    Qiqi Wang
    Pengcheng Zhang
    Ryoichi Hirayama
    Weiqiang Chen
    Xiaodong Jin
    Xiaogang Zheng
    Zhen Wang
    Qiang Li
    Cell Death Discovery, 7
12345